Old Web
English
Sign In
Acemap
>
Paper
>
Tofacitinib as a novel therapy in COVID-19 acute respiratory distress syndrome
Tofacitinib as a novel therapy in COVID-19 acute respiratory distress syndrome
2021
Pooja Singh
Rajesh Panda
Saiteja Kodamanchili
Abhijeet Anand
Keywords:
Medicine
2019 20 coronavirus outbreak
Acute respiratory distress
Coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
Tofacitinib
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]